Stocklytics Platform
Asset logo for symbol MAIA
MAIA Biotechnology
MAIA38
$2.53arrow_drop_down2.69%-$0.07
Penny Stock
Asset logo for symbol MAIA
MAIA38

$2.53

arrow_drop_down2.69%

Performance History

Chart placeholder
Key Stats
Open$2.68
Prev. Close$2.60
EPS-1.62
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$64.07M
PE Ratio-
LOWHIGH
Day Range2.51
2.71
52 Week Range0.82
5.99
Ratios
Revenue-
EBITDA Margin %-
EPS-1.62

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About MAIA Biotechnology (MAIA)

MAIA Biotechnology, Inc. (MAIA) is a biotechnology company that focuses on the development and commercialization of innovative therapies for the treatment of cancer. The company was founded in 2016 and is headquartered in San Diego, California. MAIA's mission is to transform the lives of patients by advancing the frontiers of cancer treatment and improving patient outcomes. MAIA is dedicated to delivering innovative solutions that address unmet medical needs in oncology.
MAIA's lead product candidate is MAIA-100, a novel immunotherapy designed to target and kill cancer cells while sparing healthy cells. MAIA-100 works by harnessing the power of the immune system to recognize and eliminate cancer cells. Preclinical studies have shown promising results, with MAIA-100 exhibiting potent anti-tumor activity in multiple cancer types. MAIA is currently conducting clinical trials to evaluate the safety and efficacy of MAIA-100 in patients with various forms of cancer.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Vlad Vitoc M.B.A., M.D.
Headquarters
Chicago
Employees
18
Exchange
NYSE
add MAIA Biotechnology to watchlist

Keep an eye on MAIA Biotechnology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is MAIA Biotechnology's (MAIA) price per share?

The current price per share for MAIA Biotechnology (MAIA) is $2.53. The stock has seen a price change of -$0.07 recently, indicating a -2.69% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for MAIA Biotechnology (MAIA)?

For MAIA Biotechnology (MAIA), the 52-week high is $5.99, which is 136.76% from the current price. The 52-week low is $0.82, the current price is 208.54% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is MAIA Biotechnology (MAIA) a growth stock?

MAIA Biotechnology (MAIA) has shown an average price growth of 0.41% over the past three years. It has received a score of 78 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying MAIA Biotechnology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is MAIA Biotechnology (MAIA) stock price performance year to date (YTD)?

As of the latest data, MAIA Biotechnology (MAIA) has a year-to-date price change of 112.61%. Over the past month, the stock has experienced a price change of -13.36%. Over the last three months, the change has been -25.37%. Over the past six months, the figure is 9.05%.
help

Is MAIA Biotechnology (MAIA) a profitable company?

MAIA Biotechnology (MAIA) has a net income of -$19.77M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$20.36M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of MAIA Biotechnology (MAIA)?

MAIA Biotechnology (MAIA) has a market capitalization of $64.07M. The average daily trading volume is 71.51K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media